Novartis AG (NVS)
97.50
+0.37
(+0.38%)
USD |
NYSE |
May 01, 16:00
97.65
+0.15
(+0.15%)
Pre-Market: 08:57
Novartis 1 Year Total Returns (Daily): -1.32% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | -1.32% |
| April 30, 2024 | -1.72% |
| April 29, 2024 | -1.76% |
| April 26, 2024 | -1.38% |
| April 25, 2024 | -1.19% |
| April 24, 2024 | 1.47% |
| April 23, 2024 | 0.66% |
| April 22, 2024 | -1.58% |
| April 19, 2024 | -0.10% |
| April 18, 2024 | -1.29% |
| April 17, 2024 | -1.40% |
| April 16, 2024 | -1.18% |
| April 15, 2024 | 0.10% |
| April 12, 2024 | 0.61% |
| April 11, 2024 | 2.20% |
| April 10, 2024 | 2.35% |
| April 09, 2024 | 3.29% |
| April 08, 2024 | 2.94% |
| April 05, 2024 | 4.57% |
| April 04, 2024 | 7.57% |
| April 03, 2024 | 5.86% |
| April 02, 2024 | 6.50% |
| April 01, 2024 | 8.15% |
| March 28, 2024 | 10.38% |
| March 27, 2024 | 10.22% |
| Date | Value |
|---|---|
| March 26, 2024 | 18.28% |
| March 25, 2024 | 18.85% |
| March 22, 2024 | 21.85% |
| March 21, 2024 | 19.17% |
| March 20, 2024 | 19.48% |
| March 19, 2024 | 21.62% |
| March 18, 2024 | 21.12% |
| March 15, 2024 | 22.96% |
| March 14, 2024 | 24.06% |
| March 13, 2024 | 25.89% |
| March 12, 2024 | 28.35% |
| March 11, 2024 | 30.41% |
| March 08, 2024 | 30.97% |
| March 07, 2024 | 28.89% |
| March 06, 2024 | 26.15% |
| March 05, 2024 | 25.84% |
| March 04, 2024 | 25.68% |
| March 01, 2024 | 27.08% |
| February 29, 2024 | 25.28% |
| February 28, 2024 | 26.83% |
| February 27, 2024 | 25.84% |
| February 26, 2024 | 25.86% |
| February 23, 2024 | 25.31% |
| February 22, 2024 | 23.78% |
| February 21, 2024 | 23.38% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-10.86%
Minimum
Jan 25 2022
41.88%
Maximum
Sep 26 2023
8.80%
Average
6.61%
Median
Nov 10 2022
1 Year Total Returns (Daily) Benchmarks
| Sandoz Group AG | -- |
| Amgen Inc | 20.01% |
| AstraZeneca PLC | 6.25% |
| Incyte Corp | -29.73% |
| MorphoSys AG | 227.3% |